The landscape of modern oncology is shifting rapidly from traditional monoclonal antibodies toward the frontier of complex, next-generation biologics. Among...
In a significant move to reshape its oncology portfolio ahead of impending patent cliffs, Merck & Co. has secured exclusive...
In a landmark move for the biotechnology and pharmaceutical sectors, Ginkgo Bioworks—through its data-focused arm, Ginkgo Datapoints—and the federated learning...
In the decades-long battle against Alzheimer’s disease and related "tauopathies," the scientific community has largely focused on clearing the toxic...
For families navigating the often-harrowing odyssey of undiagnosed rare diseases, the "diagnostic odyssey" is frequently marked by years of medical...
In the delicate dance of cellular life, DNA is constantly under siege. From the constant barrage of environmental stressors to...
In the high-stakes world of biopharmaceutical manufacturing, the focus is often placed on the final molecule—the complex protein therapy that...
This past week, the biotechnology sector witnessed a rare and counterintuitive phenomenon: a significant courtroom victory that translated into a...
As the biopharmaceutical landscape shifts from traditional monoclonal antibodies toward complex viral vectors, mRNA vaccines, and sophisticated cell-based therapies, the...
Every movement a human makes—from the blink of an eye to the stride of an Olympic sprinter—relies on a microscopic,...
In the quest to demystify Alzheimer’s disease, science has long looked to the brain’s neurons as the primary battlefield. However,...
In a significant breakthrough for synthetic biology and antimicrobial research, scientists at the University of Otago—Ōtākou Whakaihu Waka—in New Zealand...
